Search Result "atherogenic lipoproteins"
Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2892-2901
Author(s): S. Oravec,A. Dukat,P. Gavornik,M. Kucera,K. Gruber,L. Gaspar,M. Rizzo,P.P. Toth,D.P. Mikhailidis,M. Banach
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 894-902
Author(s): Dragana Nikolic,Giuseppa Castellino,Maciej Banach,Peter P. Toth,Ekaterina Ivanova,Alexander N. Orekhov,Giuseppe Montalto,Manfredi Rizzo
Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 8-15
Author(s): Takao Kimura, Koichi Sato, Hideaki Tomura, Fumikazu Okajima
Lipoprotein Lipase and Atherosclerosis
Journal: Current Vascular Pharmacology
Volume: 1 Issue: 1 Year: 2003 Page: 11-17
Author(s): K. Tsutsumi
Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 932-936
Author(s): Nikita G. Nikifirov,Emile R. Zakiev,Natalia V. Elizova,Vasily N. Sukhorukov,Alexander N. Orekhov
Lipoprotein Apheresis and PCSK9-Inhibitors. Impact on Atherogenic Lipoproteins and Anti-Inflammatory Mediators in Familial Hypercholesterolaemia
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3634-3637
Author(s): Claudia Stefanutti,Maria Grazia Zenti
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov
Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism
Journal: Current Diabetes Reviews
Volume: 14 Issue: 5 Year: 2018 Page: 427-433
Author(s): Jahangir Iqbal,Ali Al Qarni,Abbas Hawwari,Ahmad F. Alghanem,Gasmelseed Ahmed
Platelet Signaling Induced by Lipoproteins
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4 Issue: 2 Year: 2006 Page: 93-109
Author(s): S. J.A. Korporaal, J. W.N. Akkerman